- MY ACCOUNT
Title: Feasibility and Usability of a Mobile Application to Asses Symptoms and Affect in Patients with Atrial Fibrillation: A Pilot Study
Credits: Hamid Ghanbari, MD, MPH, Sardar Ansari, MD, Michael Ghannam, MD, Sangeeta Lathkar-Pradhan, MBBS, Anna Kratz, PhD, Hakan Oral, MD, Kayvan Najarian, PhD, Daniel Clauw, MD, Brahmajee Nallamothu, MD, MPH
Title: The Nonvitamin K Antagonist Oral Anticoagulants And Atrial Fibrillation: Challenges And Considerations
Credits: Sameer Bansilal,Anna Plitt
Title: How To Manage Oral Anticoagulation Periprocedurally During Ablations And Device Implantations
Title: Safety of the novel oral anticoagulant edoxaban for atrial fibrillation after cardiac surgery: Pilot study
Title: Symptoms in Atrial Fibrillation: A Contemporary Review and Future Directions
Title: Electrophysiological Perspectives on Hybrid Ablation of Atrial Fibrillation
Title: Review and insights into the bleeding mechanism incited by antithrombotic therapy: mechanistic nuances of dual pro-hemorrhagic substrate incorporating drug-induced microvascular leakage
Credits: Dr. Petras Stirbys
Title: Heterogeneity in the Perioperative Management of Non-Vitamin K Oral Anticoagulants in Chronic Kidney Disease
Title: My Patient Taking A Novel Oral Anticoagulant Presents With Major GI Bleeding
Title: ECG patterns in cardiac resynchronization therapy
Title: Another Successful Year of Learning and Education in Atrial Fibrillation !
Title: Initial Experience with the A Novel Flexible-Tip Irrigated Ablaton Catheter in a Case of Paroxysmal Atrial Fibrillation
Title: Risk of Ischemic Stroke and Stroke Prevention in Patients with Atrial Fibrillation and Renal Dysfunction
Title: Happy Holidays
Title: The Optimal Treatment for Atrial Fibrillation in Less Developed Countries
Title: My patient taking a novel oral anticoagulant needs surgery, device implantation, or ablation
Title: Coagulation Testing For New Oral Anticoagulants
Credits: Mehmet Demir
Title: The New Novel Oral Anticoagulants (NOACs) in Patients with Atrial Fibrillation: Dogma, Dilemmas, and Decisions on Dosing
Credits: Dr. James A. Reiffel, MD
Title: Advances in Left Atrial Appendage Occlusion Strategies
Title: Pharmacological Therapy in Stroke Prophylaxis - The New versus the Old Agents
Title: Predictors of Recurrent Atrial Tachyarrhythmias after Radiofrequency Ablation of Persistent Atrial Fibrillation
Title: Apixaban in patients with Atrial Fibrillation: A Systematic Review
Title: Complications of Radiofrequency Catheter Ablation for Atrial Fibrillation
Title: Dabigatran, a Direct Thrombin Inhibitor, in Atrial Fibrillation: Is it Already Time for a Change in Oral Anticoagulation Therapy?
Affiliation: Dr. Aryana is a classically-trained cardiac electrophysiologist at the Mercy General Hospital and Dignity Health Heart and Vascular Institute in Sacramento, California. He received his training at the Massachusetts General Hospital/Harvard Medical School in Boston, Massachusetts. His research interests include catheter ablation of atrial fibrillation and ventricular tachycardia and left atrial appendage closure as alternative therapy to oral anticoagulation. Dr. Aryana serves as an international proctor for the procedure of cryoballoon ablation of atrial fibrillation. In addition, he has a special interest in epicardial ablation. He is also the principal faculty and director of a nationally-recognized epicardial course which provides hands-on training to invasive cardiologists and cardiac electrophysiologists.
Affiliation: Dr. Terekhov is a head of Arrhythmology department of Saratov Regional Cardiac Centre, Saratov. Russia. He is certified in Cardiosurgery and Clinical Cardiac Electrophysiology. His basic clinical interests are supraventricular and ventricular tachycardia ablation and implantation of cardiac devices. As a researcher, his interests involve the management of novel oral anticoagulants and investigation of periprocedural antiocoagulation therapy complications.
Affiliation: Cardiac Arrhythmia Service, University of Michigan, Ann Arbor, MI.
Affiliation: Electrophysiology Fellow at Northwestern University in Chicago. Research interests include the management and prevention of post-operative atrial fibrillation and the use of novel oral anti-coagulants.
Affiliation: Priv.-Doz. Peter Sick, MD is director of the department of Cardiology, Hospital Barmherzige Brueder Regensburg. He is one of the pioneers in LAA-occlusion techniques. First feasibility study with the Watchman device was performed under his guidance at the Leipzig heart center and he was senior author of the protect AF-Trial, which was the first randomized comparison between LAA-occlusion and oral anticoagulation therapy in atrial fibrillation.
Affiliation: Dentist, Oromaxillofacial Trainee, Member Association of Oral & Maxillofacial Surgeons of India, Member International Association of Oral & Maxillofacial Surgeons , renowned international speaker and presenter in various international conferences, researcher, excellent in academic and leadership skills. Main research interests are oromaxillofacial surgeries in cardiac patients and complications associated mainly the trigemino-cardiac reflex (TCR).
Display Ads on JAFIB to reach Users world wide...
Suggest an Event to get good mileage from Users World wide...